Columbia researchers found that exposure to famine early in gestation—but not in the first years of life or late gestation—increased the risk of developing type 2 diabetes decades later.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Seniors with diabetes spent less out-of-pocket after the launch of Medicare’s Part D prescription drug benefit, School of Nursing researchers have found.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
The Naomi Berrie Diabetes Center at Columbia University offers free screening to qualified relatives of people with type 1 diabetes. The screening is part of a national study.
A Naomi Berrie Diabetes Center research team has discovered a pathway that prevents insulin from causing fatty liver without altering its favorable effect on blood sugar.
College of Physicians & Surgeons Dean Lee Goldman discusses his new book, which examines the role DNA plays in attempting to treat diabetes, obesity, and cardiovascular disease.